EGETIS THERAPEUTICS AB
Last · StockholmSEK 9.40-0.05 (-0.53%)close · yahoo · 6h ago
Market capSEK 4.4B465.0M sh
P/E · TTM-9.9fwd 78.3 · eps -1.00 · loss
Beta0.78vs S&P 500
Div yield0.00%annual · TTM
52w range
SEK 3.625SEK 10.14
Volume386.1Ksession
Loading chart…
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.20
Est. revenue
24.9M
Press & signals
- GlobeNewswire
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
- GlobeNewswire
Egetis Therapeutics to Participate in Upcoming Investor Conferences in September
Documents
FormReporting forFiledFlags